Stentys SA STNT-Product Pipeline Analysis, 2016 Update

Stentys SA STNT-Product Pipeline Analysis, 2016 Update

  • Products Id :- GDME2084PD
  • |
  • Pages: 23
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Stentys SA (Stentys) is a medical technology company that develops and offers solutions to cardiologists to treat patients with acute myocardial infarction and coronary disease. The company's products include BMS and DES stents, and aspiration catheter stents. Stentys's stent is designed with small distinctive interconnectors, which is implanted in the hand vessel over a single wire. The company markets products under brand names, namely, Self-Apposing and STENTYS. It has conducted clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Stentys, SA

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Stentys SA Company Snapshot 5

Stentys SA Company Overview 5

Stentys SA Pipeline Products and Clinical Trials Overview 5

Stentys SA-Pipeline Analysis Overview 7

Key Facts 7

Stentys SA-Major Products and Services 8

Stentys SA Pipeline Products by Development Stage 9

Stentys SA Pipeline Products Overview 11

Next-Generation Delivery System 11

Next-Generation Delivery System Product Overview 11

STENTYS Paclitaxel-Eluting Stent 12

STENTYS Paclitaxel-Eluting Stent Product Overview 12

STENTYS Self-Apposing Coronary Stent 13

STENTYS Self-Apposing Coronary Stent Product Overview 13

Stentys SA-Key Competitors 14

Stentys SA-Key Employees 15

Stentys SA-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Stentys SA, Recent Developments 17

Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016 17

Mar 21, 2016: STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease 17

Mar 16, 2016: STENTYS Reports 2015 Annual Results 17

Feb 29, 2016: STENTYS: Results of Self-Apposing Sirolimus-Eluting Stent Trial Published in EuroIntervention 18

Feb 08, 2016: STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication 19

Jan 28, 2016: STENTYS: First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs Broadcasted Live at LINC International Congress 19

Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues 19

Oct 15, 2015: STENTYS Reports 84% Growth in Third-Quarter 2015 Revenues 20

Oct 12, 2015: STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years 20

Sep 28, 2015: STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease 20

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22

List of Figures

Stentys SA Pipeline Products by Equipment Type 6

Stentys SA Pipeline Products by Development Stage 9

List of Tables

Stentys SA Pipeline Products and Clinical Trials Overview 5

Stentys SA Pipeline Products by Equipment Type 6

Stentys SA Pipeline Products by Indication 6

Stentys SA, Key Facts 7

Stentys SA, Major Products and Services 8

Stentys SA Number of Pipeline Products by Development Stage 9

Stentys SA Pipeline Products Summary by Development Stage 10

Next-Generation Delivery System-Product Status 11

Next-Generation Delivery System-Product Description 11

STENTYS Paclitaxel-Eluting Stent-Product Status 12

STENTYS Paclitaxel-Eluting Stent-Product Description 12

STENTYS Self-Apposing Coronary Stent-Product Status 13

STENTYS Self-Apposing Coronary Stent-Product Description 13

Stentys SA, Key Employees 15

Stentys SA, Subsidiaries 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]


Biosynex S.A.


Carmat SAS

Stentys SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53843
Site License
USD 1500 INR 107685
Corporate User License
USD 2250 INR 161528



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]